Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1635 in its research report dated January 31, 2024.
ICICI Securities recommended hold rating on Sun Pharma with a target price of Rs 1400 in its research report dated January 31, 2024.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1640 in its research report dated February 01, 2024.
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated December 08, 2023.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1280 in its research report dated November 02, 2023.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1265 in its research report dated August 03, 2023.
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated August 03, 2023.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1310 in its research report dated August 03, 2023.
Higher R&D expense, moderation of Revlimid opportunity, higher operational expenses and increased competitive intensity would weigh on the company in the near term. We remain on the sidelines
KR Choksey is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1172 in its research report dated May 31, 2023.
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1123 in its research report dated May 29, 2023.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated May 28, 2023.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 27, 2023.
Elevated promotional/travel expenses and increased competitive intensity would weigh on margins
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1175 in its research report dated February 01, 2023.
Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated January 31, 2023.
ICICI Direct is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 1210 in its research report dated February 01, 2023.
Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated December 07, 2022.
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated November 02, 2022.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1175 in its research report dated November 02, 2022.
For FY23, we continue with the estimates that the top line of Sun Pharma would grow in a high single digit only
Sharekhan is bullish on Sun Pharmaceuticals Industries has recommended buy rating on the stock with a target price of Rs 1130 in its research report dated July 29, 2022.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated July 31, 2022.
Motilal Oswal is bullish on Sun Pharma recommended buy rating on the stock with a target price of Rs 1100 in its research report dated July 30, 2022.
ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1125 in its research report dated July 30, 2022.